Abstract: A process for making cerium-containing nanoparticles with biocompatible stabilizers is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid, a stabilizer (chelator) selected from the group consisting of nitrilotriacetic acid, ethylene glycol tetraacetic acid and diethylenetriaminepentaacetic acid, and an oxidant, is provided, followed by a heating step to effectively form the nanoparticles. These biocompatible nanoparticles can be used to treat oxidative stress related diseases and events, such as ischemic stroke.

Abstract: A method of making stable aqueous dispersions and concentrates of cobalt oxide nanoparticles is described, wherein a reaction mixture comprising cobalt(II) ion, a carboxylic acid, a base, an oxidant and water is formed, and in which cobalt oxide nanoparticles are formed. Cobalt oxide nanoparticles ranging in average crystallite size from about 4 nm to 15 nm are described. The cobalt oxide nanoparticles may be isolated and redispersed to form stable, homogeneous, aqueous dispersions of cobalt oxide nanoparticles containing from about 1 to about 20 weight percent cobalt oxide.

Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, malic acid, an oxidant, and water, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of nanoceria particles. Biocompatible nanoparticles comprised of ceria and malic acid are described. A reduction in cell death in a murine model of ischemic stroke utilizing intact brain slices is demonstrated by a prophylactic treatment of ceria nanoparticles prepared with malic acid.

Abstract: Aqueous and substantially crystalline iron oxide nanoparticle dispersions and processes for making them are disclosed. The nanoparticle size and size distribution width are advantageous for use in a fuel additive for catalytic reduction of soot combustion in diesel particulate filters. Nanoparticles of the aqueous colloid are transferred to a substantially non-polar liquid comprising a carboxylic acid and one or more low-polarity solvents. The transfer is achieved by mixing the aqueous and substantially non-polar materials, forming an emulsion, followed by a phase separation into a substantially metal-free remnant polar phase and a substantially non-polar organic colloid phase. A method for rapid and substantially complete transfer of non-agglomerated nanoparticles to the low polarity phase in the presence of an organic amine, and a rapid phase separation of the substantially non-polar colloid from a remnant aqueous phase, are provided.

Abstract: A method of making stable aqueous dispersions and concentrates of cobalt oxide nanoparticles is described, wherein a reaction mixture comprising cobalt(II) ion, a carboxylic acid, a base, an oxidant and water is formed, and in which cobalt oxide nanoparticles are formed. Cobalt oxide nanoparticles ranging in average crystallite size from about 4 nm to 15 nm are described. The cobalt oxide nanoparticles may be isolated and redispersed to form stable, homogeneous, aqueous dispersions of cobalt oxide nanoparticles containing from about 1 to about 20 weight percent cobalt oxide.

Abstract: A process for making cerium-containing nanoparticles with biocompatible stabilizers is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid, a stabilizer (chelator) selected from the group consisting of nitrilotriacetic acid, ethylene glycol tetraacetic acid and diethylenetriaminepentaacetic acid, and an oxidant, is provided, followed by a heating step to effectively form the nanoparticles. These biocompatible nanoparticles can be used to treat oxidative stress related diseases and events, such as ischemic stroke.

Abstract: A process for making cerium-containing nanoparticles with biocompatible stabilizers is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid, a stabilizer (chelator) selected from the group consisting of nitrilotriacetic acid, ethylene glycol tetraacetic acid and diethylenetriaminepentaacetic acid, and an oxidant, is provided, followed by a heating step to effectively form the nanoparticles. These biocompatible nanoparticles can be used to treat oxidative stress related diseases and events, such as ischemic stroke.

Abstract: A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, malic acid, an oxidant, and water, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of nanoceria particles. Biocompatible nanoparticles comprised of ceria and malic acid are described. A reduction in cell death in a murine model of ischemic stroke utilizing intact brain slices is demonstrated by a prophylactic treatment of ceria nanoparticles prepared with malic acid.

Abstract: A process for making cerium-containing nanoparticles with biocompatible stabilizers is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid, a stabilizer (chelator) selected from the group consisting of nitrilotriacetic acid, ethylene glycol tetraacetic acid and diethylenetriaminepentaacetic acid, and an oxidant, is provided, followed by a heating step to effectively form the nanoparticles. These biocompatible nanoparticles can be used to treat oxidative stress related diseases and events, such as ischemic stroke.

Abstract: Aqueous and substantially crystalline iron oxide nanoparticle dispersions and processes for making them are disclosed. The nanoparticle size and size distribution width are advantageous for use in a fuel additive for catalytic reduction of soot combustion in diesel particulate filters. Nanoparticles of the aqueous colloid are transferred to a substantially non-polar liquid comprising a carboxylic acid and one or more low-polarity solvents. The transfer is achieved by mixing the aqueous and substantially non-polar materials, forming an emulsion, followed by a phase separation into a substantially metal-free remnant polar phase and a substantially non-polar organic colloid phase. A method for rapid and substantially complete transfer of non-agglomerated nanoparticles to the low polarity phase in the presence of an organic amine, and a rapid phase separation of the substantially non-polar colloid from a remnant aqueous phase, are provided.